查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1627953

羊膜穿刺针市场机会、成长驱动因素、产业趋势分析与预测 2024 - 2032 年

Amniocentesis Needle Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 135 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023 年，全球羊膜穿刺针市值为 1.767 亿美元，预计 2024 年至 2032 年复合年增长率为 4.9%。自体免疫疾病，这会使怀孕变得复杂并增加胎儿健康问题的风险。这些疾病以及越来越多的先天性疾病，导致对羊膜穿刺术的需求不断增长，羊膜穿刺术可以提供重要的早期诊断并改善胎儿健康的管理。

羊膜穿刺针设计和功能的技术进步有助于提高这些手术的安全性和效率。现代针具有诸如用于精确控制深度的可调式塞子和用于基于注射器的液体提取的安全连接器等功能。这些创新有助于降低胎儿和周围组织的风险，从而促进更安全的手术并增强医疗保健提供者的信心。针头设计的改进进一步推动了羊膜穿刺术作为可靠诊断工具的采用。

羊膜穿刺针市场依针长度分为三个部分：100至150毫米、小于100毫米和大于150毫米。 2023 年，100 至 150 毫米细分市场占据市场主导地位，营收达 9,220 万美元。此范围内的针非常适合进入羊膜囊，尤其是在怀孕中期，此时羊膜囊位于腹部表面下方约 8 至 12 公分处。这些针提供了提取足够羊水的最佳深度，确保准确的测试并最大限度地降低手术风险。它们的精确性和安全性使其成为临床医生进行羊膜穿刺术的首选。

市场范围
开始年份 2023年
预测年份 2024-2032
起始值 1.767 亿美元
预测值 2.726 亿美元
复合年增长率 4.9%

依手术方式，羊膜穿刺针市场包括羊膜穿刺术、羊膜减缩术、胎儿输血、羊膜腔输注术和脐带穿刺术。羊膜穿刺术占据了最大的市场份额，到2023 年占总数的33.1%。查测试无法总是证实这些疾病。

由于先天性疾病发病率较高和医疗基础设施先进，2023 年美国羊膜穿刺针市场价值为 6,260 万美元，继续保持领先地位。由于重视早期诊断和专门的产前护理，预计美国对羊膜穿刺术的需求将保持强劲，进一步推动市场成长。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 羊膜穿刺术数量不断增加
      • 先天性疾病负担日益加重
      • 准妈妈慢性病盛行率上升
      • 羊膜穿刺针的技术进步
    • 产业陷阱与挑战
      • 替代方法的可用性
      • 缺乏熟练的专业人员
  • 成长潜力分析
  • 监管环境
  • 技术景观
  • 波特的分析
  • PESTEL分析

第 4 章：竞争格局

  • 介绍
  • 公司市占率分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 战略展望

第 5 章：市场估计与预测：按产品类型，2021 - 2032

  • 主要趋势
  • 100 至 150 毫米
  • 小于100毫米
  • 大于150毫米

第 6 章：市场估计与预测：按程序，2021 - 2032

  • 主要趋势
  • 羊膜穿刺程序
  • 羊膜缩小手术
  • 胎儿输血
  • 羊膜腔灌注程序
  • 脐带穿刺程序

第 7 章：市场估计与预测：按最终用途，2021 - 2032 年

  • 主要趋势
  • 医院
  • 诊断中心
  • 诊所
  • 其他最终用户

第 8 章：市场估计与预测：按地区，2021 - 2032

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 9 章：公司简介

  • Becton, Dickinson and Company
  • Biopsybell
  • Cardinal Health
  • Eurosurgical
  • Laboratoire CCD
  • MDL
  • McKesson Corporation
  • Medax
  • Medline Industries
  • Moller Medical
  • RI.MOS
  • Roko
  • Suzhou Leapmed Healthcare Corporation
  • The Cooper Companies
  • Vigeo
简介目录
Product Code: 8186

The Global Amniocentesis Needle Market was valued at USD 176.7 million in 2023 and is projected to grow at 4.9% CAGR from 2024 to 2032. A key factor driving this market is the rising prevalence of chronic conditions in pregnant women, such as diabetes, hypertension, and autoimmune disorders, which can complicate pregnancies and increase the risk of fetal health issues. These conditions, alongside a growing number of congenital disorders, are contributing to the rising demand for amniocentesis procedures, which offer critical early diagnosis and improved management of fetal health.

Technological advancements in the design and functionality of amniocentesis needles help enhance the safety and efficiency of these procedures. Modern needles have features like adjustable stoppers for precise depth control and secure connectors for syringe-based fluid extraction. These innovations help reduce risks to the fetus and surrounding tissues, thus promoting safer procedures and increasing confidence among healthcare providers. The improvements in needle design are further boosting the adoption of amniocentesis as a reliable diagnostic tool.

The amniocentesis needle market is categorized by needle length into three segments: 100 to 150 mm, smaller than 100 mm, and larger than 150 mm. The 100 to 150 mm segment dominated the market in 2023, generating USD 92.2 million in revenue. Needles in this range are ideal for accessing the amniotic sac, especially during the second trimester when the sac is positioned approximately 8 to 12 cm below the abdominal surface. These needles offer optimal depth for extracting sufficient amniotic fluid, ensuring accurate testing and minimizing procedural risks. Their precision and safety features make them a preferred choice for clinicians performing amniocentesis.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$176.7 Million
Forecast Value$272.6 Million
CAGR4.9%

By procedure, the amniocentesis needle market includes amniocentesis, amnioreduction, fetal blood transfusions, amnioinfusion, and cordocentesis. Amniocentesis procedures represented the largest market share, accounting for 33.1% of the total in 2023. Known for its high accuracy, amniocentesis is particularly effective in providing conclusive diagnoses, such as detecting genetic conditions like Down syndrome, which screening tests cannot always confirm.

The U.S. amniocentesis needle market, valued at USD 62.6 million in 2023, continues to lead due to a higher incidence of congenital disorders and an advanced healthcare infrastructure. With an emphasis on early diagnosis and specialized prenatal care, the demand for amniocentesis is expected to remain strong in the U.S., further driving market growth.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing number of amniocentesis procedures
      • 3.2.1.2 Growing burden of congenital disorders
      • 3.2.1.3 Rising prevalence of chronic diseases among expectant mothers
      • 3.2.1.4 Technological advancements in amniocentesis needles
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Availability of alternative methods
      • 3.2.2.2 Dearth of skilled professionals
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy outlook

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 100 to 150 mm
  • 5.3 Smaller than 100 mm
  • 5.4 Larger than 150 mm

Chapter 6 Market Estimates and Forecast, By Procedure, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Amniocentesis procedures
  • 6.3 Amnioreduction procedures
  • 6.4 Fetal blood transfusions
  • 6.5 Amnioinfusion procedures
  • 6.6 Cordocentesis procedures

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Diagnostic centers
  • 7.4 Clinics
  • 7.5 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 Becton, Dickinson and Company
  • 9.2 Biopsybell
  • 9.3 Cardinal Health
  • 9.4 Eurosurgical
  • 9.5 Laboratoire CCD
  • 9.6 M.D.L
  • 9.7 McKesson Corporation
  • 9.8 Medax
  • 9.9 Medline Industries
  • 9.10 Moller Medical
  • 9.11 RI.MOS
  • 9.12 Roko
  • 9.13 Suzhou Leapmed Healthcare Corporation
  • 9.14 The Cooper Companies
  • 9.15 Vigeo